USPTO serial 79447893
DNDI BEST SCIENCE FOR THE MOST NEGLECTED
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- AMPONSAH, OHENEBA K
- Law office
- TMO LAW OFFICE 113
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DNDI BEST SCIENCE FOR THE MOST NEGLECTED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marc P. Misthal
Marc P. Misthal Offit Kurman, P.A.590 Madison Avenue, 6th FloorNew York, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Arranging and conducting of educational courses in the field of medicine and health; arranging and conducting training courses in the field of medicine and health; organizing and conducting of conferences and seminars in the field of medicine and health; arranging and conducting of congresses in the field of medicine and health; conducting of colloquiums in the field of medicine and health; publication of books and magazines in the field of medicine and health; providing online non-downloadable electronic publications in the nature of magazines, newsletters, brochures and factsheets in the field of medicine and health | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research in the field of bacteriology and virology; medical research; biological research; scientific research in the field of bacteriology and virology; scientific research for medical purposes in the field of disease, namely, Chagas disease, cryptococcal meningitis, cutaneous and visceral leishmaniasis, dengue, sleeping sickness, mycetoma, pediatric HIV, Hepatitis C and parasitic worms; scientific research in the nature of conducting clinical trials for others | ACTIVE | — |
| 044 | Medical services; medical assistance; medical testing for diagnostic and treatment purposes; medical examination; pathological examination for medical diagnosis and treatment; preparation and dispensing of medications; medical screening services in the field of diseases, namely, Chagas disease, cryptococcal meningitis, cutaneous and visceral leishmaniasis, dengue, sleeping sickness, mycetoma, pediatric HIV, Hepatitis C and parasitic worms; consulting services in the field of medicine and pharmaceuticals; provision of medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 19, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 18, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 31, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |